CFP and systemic lupus erythematosus: Recapitulating the beneficial effect of properdin deficiency for lupus glomerulonephritis using a validated anti mouse properdin antibody [38] would provide proof-of-principle that serum properdin is the dominant factor in determining disease activity and lupus phenotype.